DE69528527D1 - Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus - Google Patents

Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus

Info

Publication number
DE69528527D1
DE69528527D1 DE69528527T DE69528527T DE69528527D1 DE 69528527 D1 DE69528527 D1 DE 69528527D1 DE 69528527 T DE69528527 T DE 69528527T DE 69528527 T DE69528527 T DE 69528527T DE 69528527 D1 DE69528527 D1 DE 69528527D1
Authority
DE
Germany
Prior art keywords
diagnostic methods
cartilage
compositions relating
growing
proteoglycan proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69528527T
Other languages
English (en)
Other versions
DE69528527T2 (de
Inventor
Amanda Jane Fosang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of DE69528527D1 publication Critical patent/DE69528527D1/de
Application granted granted Critical
Publication of DE69528527T2 publication Critical patent/DE69528527T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69528527T 1994-07-07 1995-06-30 Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus Expired - Lifetime DE69528527T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM6668A AUPM666894A0 (en) 1994-07-07 1994-07-07 Diagnostic methods and compositions
PCT/AU1995/000395 WO1996001847A1 (en) 1994-07-07 1995-06-30 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown

Publications (2)

Publication Number Publication Date
DE69528527D1 true DE69528527D1 (de) 2002-11-14
DE69528527T2 DE69528527T2 (de) 2003-06-26

Family

ID=3781236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528527T Expired - Lifetime DE69528527T2 (de) 1994-07-07 1995-06-30 Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus

Country Status (8)

Country Link
EP (1) EP0769025B1 (de)
JP (1) JPH10502807A (de)
AT (1) ATE225807T1 (de)
AU (1) AUPM666894A0 (de)
CA (1) CA2194352C (de)
DE (1) DE69528527T2 (de)
DK (1) DK0769025T3 (de)
WO (1) WO1996001847A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998007035A1 (en) * 1996-08-15 1998-02-19 Novartis Ag Assay for quantifying arthritic conditions
EP0998572A2 (de) 1997-07-25 2000-05-10 Du Pont Pharmaceuticals Company Aggrecan abbauende metalloproteasen
WO2000005256A1 (en) * 1998-07-24 2000-02-03 Du Pont Pharmaceuticals Company Assays and peptide substrate for determining aggrecan degrading metallo protease activity
SE9904236D0 (sv) 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
EP1670486A4 (de) * 2003-10-01 2009-04-01 Optimer Pharmaceuticals Inc Behandlung eines zustands in einem säugetier mit verabreichung von aminozucker und verwendungen davon
JP6112427B2 (ja) 2012-03-13 2017-04-12 国立大学法人 岡山大学 リジンオリゴマー誘導体及びそれからなる軟骨組織マーカー

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5387504A (en) * 1992-09-30 1995-02-07 Merck & Co., Inc. Monospecific antibodies and assay system for detecting stromelysin cleavage products

Also Published As

Publication number Publication date
AUPM666894A0 (en) 1994-07-28
CA2194352A1 (en) 1996-01-25
CA2194352C (en) 2007-01-09
DE69528527T2 (de) 2003-06-26
JPH10502807A (ja) 1998-03-17
ATE225807T1 (de) 2002-10-15
DK0769025T3 (da) 2003-02-10
EP0769025A1 (de) 1997-04-23
WO1996001847A1 (en) 1996-01-25
EP0769025B1 (de) 2002-10-09
EP0769025A4 (de) 1999-06-16

Similar Documents

Publication Publication Date Title
EA200100485A1 (ru) Соединение сдлс и способ его измерения
DE60041761D1 (de) Tribonektine
EA200101037A1 (ru) Соединения и способы для лечения и диагностики рака легкого
PT813525E (pt) Derivados de benzamidina e sua utilizacao como anticoagulantes
EA200301158A1 (ru) Антитела, блокирующие cripto, и их применения
EA200000358A1 (ru) Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2
PT866720E (pt) Proteina ob para aumentar a massa do tecido mole
EA199800798A1 (ru) Новые замешенные циклические аминокислоты в качестве фармацевтических агентов
BR0314380A (pt) Ativação de metaloprotease de miostatina e métodos de modulação da atividade de miostatina
EA200201138A1 (ru) Пептид, модулирующий рецептор тромбопоэтина
PT888271E (pt) Derivados de benzamidina substituidos com derivados de aminoacidos e hidroxiacidos e sua utilizacao como anticoagulantes
DE69528527T2 (de) Diagnostische verfahren und zusammensetzungen, die bezug nehmen auf proteoglykan-proteine des knorpelobbaus
PT948604E (pt) Produtos e metodos relacionados com pyk2
TR200103551T2 (tr) Amiloid protein birikimini önleme ve amiloid tortularını görüntüleme metodu
AU2001233913A1 (en) Bcmp 84, a protein associated to breast cancer
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE59811488D1 (de) Verfahren und Vorrichtung zur Umschaltung zwischen verschiedenen Ausgangssignal-Arten einer Positionsmesseinrichtung
DE50212280D1 (de) Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
DE60230147D1 (de) Verfahren zur überwachung und modulierung von proteinfaltung
PL336897A1 (en) Novel salts of bpc peptides, pharmaceutic compositions conatining them and method of obtaining such salts
ES2187552T3 (es) Un sistema de medicion, principalmente ambulatoria, por medio de un electrodo.
BRPI0408077A (pt) composições e métodos para prevenção e tratamento de doenças relacionadas com endotoxina e condições
BRPI0412477A (pt) aperfeiçoados polipeptìdeos de interferon-beta-1b recombinantes humanos
ATE312914T1 (de) Rdgb-proteine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition